Atypical Kawasaki disease, recombination events and antiviral therapy updates (Podcast Episode 26)

This episode is shared from Mayo Clinic Q&A.

Guest: Gregory A. Poland, M.D. (@drgregpoland)

Host: Halena M. Gazelka, M.D. (@hmgazelkamd)

On the Mayo Clinic Q&A podcast, Gregory A. Poland, M.D., an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group, discusses how SARS-CoV-2 is mutating, the atypical Kawasaki disease emerging in pediatric patients, updates in antiviral therapies, and how scientists and researchers are rapidly gaining new knowledge about the virus and the disease that it causes.

AskMayoExpert COVID-19 Navigator resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 

This education is supported in part by an independent medical education grant from Pfizer Inc. and is in accordance with ACCME guidelines.

Click here to claim credit and view faculty disclosures. Select Register to begin the credit claim process. 

Connect with Mayo Clinic School of Continuous Professional Development online at https://ce.mayo.edu or on Twitter @MayoMedEd.


Published

August 6, 2020

Created by

Mayo Clinic